Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Epub 2022 Jul 8
Cell , 103 , 239252
Their website references a 6-month clinical trial of 180 participants taking semaglutide or tirzepatide alongside the WW Clinic programme (Heinberg et al.)
marketed as Zadaxin in 35+ countries BPC-157 typical research dose / 200 to 500 mcg per day subcutaneous or oral, split or single injection Thymosin Alpha-1 typical research dose / 1.6 mg subcutaneous twice weekly (standard Zadaxin dosing) Primary BPC-157 mechanism / upregulates growth hormone receptor, promotes angiogenesis and collagen synthesis Primary Thymosin Alpha-1 mechanism / activates Toll-like receptor 9, drives Th1 CD4+ and CD8+ T-cell maturation Evidence quality for BPC-157 / animal models and case series
Along with whole grains, fruits, and vegetables, aim for adequate daily protein to support your training and recovery
